Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Brain Inj. 2011;25(1):101–112. doi: 10.3109/02699052.2010.536194

Table III.

Cognitive testing, CRC and demographic data. All cognitive test data are shown as T-scores.

LMM

Time 1 Mean (SD) (n = 23) Time 2 Mean (SD) (n = 17) slope p d
Processing Speed Index 44.1 (9.9) 55.6 (9.9) 9.87 0.002 1.0
Working Memory Index 49.1 (9.7) 51.5 (10.3) 2.82 0.10 0.29
Sort Test 37.6 (11.3) 48.7 (7.4) 10.56 0.001 1.1
Cancellation 44.9 (12.1) 50.1 (13.2) 3.65 0.12 0.30
List Memory 43.6 (11.1) 50.9 (13.5) 6.55 0.03 0.59
Picture Memory 38.4 (10.2) 48.4 (8.1) 6.24 0.02 0.61
MVPT3 44.8 (22.7) 63.8 (11.3) 7.58 0.09 0.33
Full Scale IQ 50.8 (10.3)
Age at participation (years) 12.6 (4.1)
Age at diagnosis (years) 6.5 (3.7), 2.3–14
Last anti-cancer TX (months) 37.3 (30.1), 6–126
Males 61%
Minority status 52%
Maternal education (years) 17.7 (2.0)
CRC duration (weeks) 14 (7.5)

‘average’ range for T-score = 44–56. MVPT3 = Motor-free Visual Perception Test; Last TX = months since all anti-cancer treatments were completed; CRC = Cognitive Rehabilitation Curriculum; SD = standard deviation, p = significance value (alpha), d = effect size, LMM = Linear Mixed Model.